A review of Sativex safety data found the cannabis-based medicine was generally well-tolerated for MS spasticity, with no evidence of physiological dependence, dose escalation, or significant withdrawal effects upon stopping.
Read this if you are considering Sativex and have concerns about dependence or tolerance.
No dose escalation observed after initial titration in clinical trials or practice
What the researchers found
The reviewer evaluated published data on Sativex safety across several concern areas. Adverse effects occurred relatively frequently but were usually mild to moderate and rarely required stopping the medication. No dose escalation was observed in clinical trials or practice after the initial titration period.
When patients stopped using Sativex, symptoms often returned (confirming therapeutic effect), but no evidence of physiological or psychological dependence was observed. Sudden cessation was generally safe. Benefits observed initially were maintained during long-term treatment, arguing against tolerance development.
Why it matters
One of the biggest concerns about any cannabis-based medicine is the potential for dependence and abuse. This review addressed those concerns directly, finding that Sativex in the MS spasticity context did not produce the dependence patterns associated with recreational cannabis use.
The numbers in context
Initial pilot study from 2004. Long-term treatment maintained benefits. No dose escalation after initial titration. Adverse effects usually mild to moderate. No evidence of physiological or psychological dependence upon withdrawal.
How the study worked
Narrative review of published clinical trial data, long-term follow-up studies, and clinical practice experience from the Oxford Centre for Enablement. Evaluated tolerability, psychoactivity, withdrawal effects, tolerance, and abuse potential.
What this study cannot tell us
The review came primarily from one research center's experience, which may not represent all clinical settings. Patients in clinical trials are monitored more closely than typical patients. The MS patient population may not be representative of how the drug would behave in other populations.
How to read the evidence
Narrative review of clinical trial and clinical practice data from a single center; moderate evidence for safety profile.
When this study was published
Published in 2012. Additional long-term safety data has accumulated since with continued real-world use.
The bigger picture
The safety profile described here was important for Sativex's regulatory journey. Demonstrating that a cannabis-derived medicine could be used long-term without dependence or dose escalation helped distinguish pharmaceutical cannabinoid use from recreational cannabis and supported broader acceptance of cannabinoid medicines.
Questions still open
- Does the safety profile hold in real-world prescribing outside of clinical trial monitoring? Would other patient populations show different dependence patterns? How does long-term Sativex safety compare to other long-term MS medications?
Common questions
Can you become dependent on Sativex?
Do patients need to increase their Sativex dose over time?
Read the original research
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough?
Expert review of neurotherapeutics, 12(4 Suppl), 9-14
Citation
Wade, Derick. (2012). Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough?. Expert review of neurotherapeutics, 12(4 Suppl), 9-14. https://doi.org/10.1586/ern.12.12
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Physical vs Psychological Cannabis Dependence: What Science Actually Shows
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- The Gap Between Cannabis Perception and Science: Why What We Believe Outpaces What We Know
- Cannabis Use Disorder: Am I Addicted? Self-Assessment Guide
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- Cross-Addiction After Quitting Weed: When One Habit Replaces Another
- Is Weed Addictive? What the Research Actually Shows
- Is Cannabis Addictive? What the DSM-5 and Brain Science Say
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed and Alcohol Together: What to Know About Dual Cessation
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Is Rehab Necessary for Weed? An Honest Assessment
- Cannabis and Older Adults: Risks Seniors Should Know
- Signs You May Have Cannabis Use Disorder: An Honest Self-Assessment
- Cannabis and Breastfeeding: THC in Breast Milk
- Weed Vape Pen Addiction: Why Vaping Makes It Harder to Quit
- Being High 24/7: What Happens to Your Brain and Body with Constant THC
- Optimal Tolerance Break Length: What the Science Says About Reset Timing
- What Happens to Your Body When You're High 24/7 for Months